Katie Carter

The Burges Salmon team advising Calcivis was led by senior associate Katie Carter, partner Danny Lee, solicitor Will Penfold and trainee solicitor Anousha Al-Masoud from the firm’s corporate and M&A team. The firm initially advised Calcivis on its equity investment by Archangels in 2021 and again on a follow on investment in 2022.

Ms Carter said: “Scotland is home to many biotech companies whose cutting-edge technologies are set to revolutionise healthcare and Calcivis is a prime example of that.

“We’re thrilled to have worked once again with the company and to see it grow from strength to strength with this latest investment round supporting its ambitious expansion plans in the UK, Europe and the US, the largest market for medical technology.”

Adam Christie, CEO of Calcivis, added: “It’s always a pleasure working with the Burges Salmon team and we’re grateful for their excellent advice throughout the whole process.

“The firm really understands what we need and how we like to work, and they adeptly guide us through investment process complexities with ease.”